TeraImmune, Inc.
Biotechnology company · Germantown, Maryland, United States
TeraImmune, Inc. is a biotechnology company headquartered in Germantown, Maryland, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,941 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2022.
TeraImmune at a glance
What does TeraImmune do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $224,941 in total (2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3 million sold (2022).
Frequently asked questions about TeraImmune
Where is TeraImmune headquartered?
TeraImmune, Inc. is headquartered in Germantown, Maryland, United States.
What does TeraImmune do?
TeraImmune, Inc. is a biotechnology company.
When was TeraImmune founded?
The earliest incorporation on record for TeraImmune, Inc. is in 2019, according to public company registers.
Similar companies
- Neuralstem, Inc.Germantown, Maryland, United States
- Deka Biosciences, Inc.Germantown, Maryland, United States
- Neuraly, Inc.Germantown, Maryland, United States
- Verachem LLCGermantown, Maryland, United States
- C-Motion, Inc.Germantown, Maryland, United States
- Zalgen LabsGermantown, Maryland, United States
- Senseonics Holdings, Inc.Germantown, Maryland, United States
- HBVtechGermantown, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences